These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1474881)

  • 1. [The dexamethasone test and the choice of treatment and drug in depression].
    Fornaro P; Lippi P; Allegretti M
    Minerva Psichiatr; 1992; 33(3):177-83. PubMed ID: 1474881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dexamethasone test: suppressors and non-suppressors, what's the difference?].
    Vandel S; Bonin B; Vandel B; Allers G; Volmat R
    Encephale; 1985; 11(4):157-62. PubMed ID: 2935387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objectifying psychiatric diagnosis and treatment with the dexamethasone suppression test.
    Pollock DC; Sheehan ME
    J Fam Pract; 1982 Oct; 15(4):641-5. PubMed ID: 6288832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - physiological and clinical construct validity of the DST.
    Holsboer F
    Pharmacopsychiatria; 1983 Nov; 16(6):186-91. PubMed ID: 6665028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.
    Jokinen J; Nordström P
    Psychoneuroendocrinology; 2008 Nov; 33(10):1387-93. PubMed ID: 18805641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
    Sanchez Blanque A; Fernandez Canti G; Gimenez Morales JC; Juste Rullo G
    Acta Psychiatr Belg; 1985; 85(3):406-15. PubMed ID: 4050499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible clinical applications of laboratory tests in depression.
    Fiori M; Davis KL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):6-11. PubMed ID: 6370977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.